Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 3, 2010, Pages

  Rose, Jennifer B ^a,b   Naydenova, Zlatina ^a   Bang, Andrew ^a   Eguchi, Megumi ^a   Sweeney, Gary ^a,b   Choi, Doo Sup ^c   Hammond, James R ^d   Coe, Imogen R ^a,b  

^a YORK UNIVERSITY   (Canada)

^b YORK UNIVERSITY   (Canada)

^c MAYO GRADUATE SCHOOL   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Adenosine; Cardiomyocytes; Cardiovascular; Hypoxia

Indexed keywords

EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER PROTEIN 3; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER PROTEIN 4; PURINE NUCLEOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; FEMALE; HEART; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MOUSE; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; FEMALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PURINE NUCLEOSIDES; RECEPTORS, PURINERGIC P1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 77749254666     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00711.2009     Document Type: Article

References (48)

1. Aymerich I, Foufelle F, Ferre P, Casado J, Pastor-Anglada M. Extracellular adenosine activates AMP-dependent protein kinase (AMPK). J Cell Sci 119: 1612-1621, 2006.
2. Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, Sun L, Tellez J, Ritzel WL, Claycomb WC, Cass CE, Young JD, Billeter-Clark R, Boyett MR, Baldwin SA. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 99: 510-519, 2006.
3. Brunt KR, Tsuji MR, Lai JH, Kinobe RT, Durante W, Claycomb WC, Ward C, Melo LG. Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes. Exp Biol Med 234: 582-594, 2009.
4. Cass CE, Gaudette LA, Paterson AR. Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane. Biochim Biophys Acta 345: 1-10, 1974.
5. Chaudary N, Naydenova Z, Shuralyova I, Coe IR. Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1. Cardiovasc Res 61: 780-788, 2004.
6. Chaudary N, Shuralyova I, Liron T, Sweeney G, Coe IR. Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes. Biochem Cell Biol 80: 655-665, 2002.
7. Chen J, Rinaldo L, Lim SJ, Young H, Messing RO, Choi DS. The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice. Genes Brain Behav 6: 776-783, 2007.
8. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci A, Messing RO. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7: 855-861, 2004.
9. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ Jr. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95: 2979-2984, 1998.
10. Coe IR, Yao L, Diamond I, Gordon AS. The role of protein kinase C in cellular tolerance to ethanol. J Biol Chem 271: 29438-29472, 1996.
11. Coe IR, Zhang Y, McKenzie T, Naydenova Z. PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS letters 517: 201-205, 2002.
12. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaka J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM. Regulation of myocardial contractility and cell size by distinct PI3KPTEN signaling pathways. Cell 110: 737-749, 2002.
13. da Silva CG, Jarzyna R, Specht A, Kaczmarek E. Extracellular nucleotides and adenosine independently activate AMP-activated protein kinase in endothelial cells. Circ Res 98: e39-e47, 2006.
14. Eckel T, Krahn T, Grenz A, Kohler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK. Cardioprotection by ecto-5=-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590, 2007.
15. Eckle T, Grenz A, Kohler D, Redel A, Falk M, Rolauffs B, Osswald H, Kehl F, Eltzschig HK. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 291: H2533-H2540, 2006.
16. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schönfeld C, Löffler M, Reyes G, Duszenko M, Karhausen J, Robinson A, Westerman KA, Coe IR, Colgan SP. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202: 1493-1505, 2005.
17. -/- mouse erythrocytes. J Pharmacol Exp Ther 329: 387-398, 2009.
18. Fredholm BB, Jzerman IAP, Jacobson KA, Klotz KN, Linden J. International union of pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552, 2001.
19. Griffiths M, Beaumont N, Yao SYM, Sundaram M, Boumah CE, Davies A, Kwong FYP, Coe I, Cass CE, Young JD, Baldwin SA. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 3: 89-93, 1997.
20. Guns PJ, Van Assche T, Fransen P, Robaye B, Boeynaems JM, Bult H. Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice. Br J Pharmacol 147: 569-574, 2006.
21. Haneskog L, Lundqvist A, Lundahl P. Biomembrane affinity chromatographic analysis of nitrobenzylthioinosine binding to the reconstituted human red cell nucleoside transporter. J Mol Recognit 11: 58-61, 1998.
22. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused heart. Am J Physiol Heart Circ Physiol 285: H1797-H1818, 2003.
23. Heidland UE, Heintzen MP, Schwartzkopff B, Strauer BE. Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine. Am Heart J 140: 813-820, 2000.
24. Hyde RJ, Cass CE, Young JD, Baldwin SA. The ENT family of eukaryotes nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18: 53-63, 2001.
25. Kohler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, Laucher S, Hart ML, Robson SC, Muller CE, Eltzschig HK. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116: 1784-1794, 2007.
26. Kong W, Engel K, Wang J. Mammalian nucleoside transporters. Curr Drug Metab 5: 63-84, 2004.
27. Krinke D, Jahnke HG, Pänke O, Robitzki AA. A microelectrode-based sensor for label-free in vitro detection of ischemic effects on cardiomyocytes. Biosens Bioelectron 24: 2798-2803, 2009.
28. 1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol 22: 39-47, 1990.
29. Leung GPH, Tse CM, Man RYK. Characterization of adenosine transport in H9c2 cardiomyoblasts. Int J Cardiol 116: 186-193, 2007. 30. Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 67: 1385-1387, 2005.
30. Lu H, Chen C, Klaassen C. Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice. Drug Metab Dispos 32: 1455-1461, 2004.
31. Mentzer RM, Rahko PS, Molina-Viamonte V, Canver CC, Chopra PS, Love RB, Cook TD, Hegge JO, Lasley RD. Safety, tolerance and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol 79: 38-43, 1997.
32. Molina-Arcas M, Trigueros-Motos L, Casado FJ, Pastor-Anglada M. Physiological and pharmacological roles of nucleoside transporter proteins. Nucleosides, Nucleotides & Nucleic Acids 27: 769-778, 2008.
33. 1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes. Am J Physiol Heart Circ Physiol 291: H1875-H1882, 2006.
34. Mubagwa K, Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovascular Res 52: 25-39, 2001.
35. Murry C, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
36. Naydenova Z, Rose JB, Coe IR. Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line. Am J Physiol Heart Circ Physiol 294: H2687-H2692, 2008.
37. Parkinson FE, Xiong W, Zamzow CR, Chestley T, Mizuno T, Duckworth ML. Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neurons. J Neurochem 109: 562-572, 2009.
38. Pelleg A, Pennock RS, Kutalek SP. Proarrhythimic effects of adenosine: one decade of clinical data. Am J Ther 9: 141-147, 2002.
39. Pennycooke M, Chaudary N, Shuralyova I, Zhang Y, Coe IR. Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem Biophys Res Commun 280: 951-959, 2001.
40. Plagemann PG, Wohlhueter RM. Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine. Biochim Biophys Acta 773: 39-52, 1984.
41. Rose JB, Coe IR. Nucleoside transporters: back to the future. Physiology 23: 41-48, 2008.
42. Sambrano GR, Fraser I, Han H, Ni Y, O'Connell T, Yan Z, Stull JT. Navigating the signalling network in mouse cardiac myocytes. Nature 420: 712-714, 2002.
43. Sanada S, Kitakaze M. Ischemic preconditioning: emerging evidence, controversy and translational trials. Inter J Cardiol 97: 263-276, 2004.
44. Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16: 349-360, 2004.
45. White S, Constantin P, Claycomb W. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 286: H823-H829, 2004.
46. Yang J, Jiang H, Yang J, Ding JW, Chen LH, Li S, Zhang XD. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLKR4/NF-kappaB signalling pathway. Mol Cell Biochem 330: 39-46, 2009.
47. Yang JN, Tiselius C, DarÉ E, Johansson B, Valen G, Fredholm BB. Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol 190: 63-75, 2007.
48. Young JD, Yao SY, Sun L, Cass CE, Baldwin SA. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 38: 995-1021, 2008.